Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The prognostic significance of preoperative platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients operated for non-small cell lung cancer
M Łochowski, J Chałubińska-Fendler… - Cancer Management …, 2021 - Taylor & Francis
Introduction The aim of the study was to determine the prognostic significance of PLR and
NLR ratios in patients operated due to non-small cell lung cancer. Material The study group …
NLR ratios in patients operated due to non-small cell lung cancer. Material The study group …
Prognostic factors determining survival of patients operated for non-small cell lung cancer with consideration given to morphological parameters of blood
M Łochowski, B Łochowska… - Cancer Management …, 2021 - Taylor & Francis
Introduction Prognostic biomarkers are the area of high interest in non-small cell lung cancer
(NSCLC). Inflammatory blood markers can be routinely determined from complete blood …
(NSCLC). Inflammatory blood markers can be routinely determined from complete blood …
A retrospective cohort study on pretreated neutrophil-to-lymphocyte ratio and prognosis of small cell lung cancer: evidence of effect modification by chemotherapy …
F Liu, S Zhou, L Tan, H Jiang… - Cancer Management and …, 2020 - Taylor & Francis
Purpose Neutrophil-to-lymphocyte ratio (NLR) has been suggested as an independent risk
factor for progression-free survival (PFS) and overall survival (OS) in small cell lung cancer …
factor for progression-free survival (PFS) and overall survival (OS) in small cell lung cancer …
[HTML][HTML] Can some inflammatory parameters predict the survival of patients with malignant pleural effusion?
ND Ozkan, A Bas, A Scheed, M Vogl… - Turkish Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Background This study aimed to investigate whether there is a correlation between some
serum inflammatory markers and the survival of patients with malignant pleural effusions …
serum inflammatory markers and the survival of patients with malignant pleural effusions …